1. Home
  2. Analysis
  3. Fioricet
  4. Metoprolol-succinate

Fioricet and Metoprolol succinate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fioricet and Metoprolol succinate. Common interactions include balance disorder among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people who take Fioricet and Metoprolol succinate have. It is created by eHealthMe based on reports of 92 people who take Fioricet and Metoprolol succinate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 31, 2023

92 people who take Fioricet and Metoprolol succinate together, and have interactions are studied.

What is Fioricet?

Fioricet has active ingredients of acetaminophen; butalbital; caffeine. It is often used in migraine. eHealthMe is studying from 11,370 Fioricet users for its effectiveness, alternative drugs and more.

What is Metoprolol succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 54,916 Metoprolol succinate users for its effectiveness, alternative drugs and more.

Number of Fioricet and Metoprolol succinate reports submitted per year:

Fioricet and Metoprolol succinate drug interactions.

Common Fioricet and Metoprolol Succinate drug interactions by gender *:

female:

  1. Balance disorder
  2. Drug ineffective
  3. Fall
  4. Nausea
  5. Pain
  6. Pre-existing condition improved
  7. Rash
  8. Renal failure
  9. Abdominal discomfort
  10. Anaemia

male:

  1. Dyspnoea
  2. Eye pain
  3. Presyncope
  4. Troponin increased
  5. Abdominal pain
  6. Adrenal insufficiency
  7. Aggression
  8. Amnesia
  9. Anaemia
  10. Angina pectoris

Common Fioricet and Metoprolol Succinate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Orthostatic hypotension
  2. Fluid imbalance
  3. Activated partial thromboplastin time prolonged
  4. Aggression
  5. Agitation
  6. Anaemia
  7. Anxiety
  8. Asthma
  9. Bacterial infection
  10. Blood bicarbonate decreased

30-39:

  1. Aneurysm
  2. Cerebrovascular accident
  3. Autonomic nervous system imbalance
  4. Bladder spasm
  5. Enuresis
  6. Pruritus
  7. Seizure
  8. Vertigo
  9. Vision blurred

40-49:

  1. Lacunar infarction
  2. Myocardial infarction
  3. Pyrexia
  4. Anorexia
  5. Anosmia
  6. Asthenia
  7. Blood triglycerides increased
  8. Cerebral haemorrhage
  9. Cerebrovascular accident
  10. Chills

50-59:

  1. Bone pain
  2. Chronic kidney disease
  3. Crying
  4. Depression
  5. Discomfort
  6. Drug ineffective
  7. Dysphagia
  8. Fatigue
  9. Intervertebral disc injury
  10. Intervertebral disc protrusion

60+:

  1. Dyspnoea
  2. Eye pain
  3. Blood pressure fluctuation
  4. Dizziness
  5. Extrasystoles
  6. Hyperhidrosis
  7. Bronchiectasis
  8. Decreased appetite
  9. Dementia alzheimer's type
  10. Diarrhoea

Common conditions people have *:

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 22 people, 23.91%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 14.13%
  3. Pain: 11 people, 11.96%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 10.87%
  5. Headache (pain in head): 9 people, 9.78%
  6. Nausea (feeling of having an urge to vomit): 7 people, 7.61%
  7. Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 5.43%
  8. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 5 people, 5.43%
  9. High Blood Cholesterol: 5 people, 5.43%
  10. Depression: 5 people, 5.43%

* Approximation only. Some reports may have incomplete information.

Do you take Fioricet and Metoprolol succinate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Fioricet and Metoprolol succinate interactions:

Browse all drug interactions of Fioricet and Metoprolol succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fioricet side effects:

Browse all side effects of Fioricet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Metoprolol succinate side effects:

Browse all side effects of Metoprolol succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Fioricet interactions:

Browse all interactions between Fioricet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Metoprolol succinate interactions:

Browse all interactions between Metoprolol succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; butalbital; caffeine and metoprolol succinate (the active ingredients of Fioricet and Metoprolol succinate, respectively), and Fioricet and Metoprolol succinate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Fioricet and Metoprolol succinate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.